314 related articles for article (PubMed ID: 24897928)
61. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
[TBL] [Abstract][Full Text] [Related]
62. Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico.
Hoyo-Ulloa I; Belaunzarán-Zamudio PF; Crabtree-Ramirez B; Galindo-Fraga A; Pérez-Aguinaga ME; Sierra-Madero JG
Int J Infect Dis; 2011 Jun; 15(6):e408-14. PubMed ID: 21493116
[TBL] [Abstract][Full Text] [Related]
63. Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?
Breen RA; Smith CJ; Cropley I; Johnson MA; Lipman MC
AIDS; 2005 Jul; 19(11):1201-6. PubMed ID: 15990574
[TBL] [Abstract][Full Text] [Related]
64. Survival rate and mortality risk factors among TB-HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study.
Aung ZZ; Saw YM; Saw TN; Oo N; Aye HNN; Aung S; Oo HN; Cho SM; Khaing M; Kariya T; Yamamoto E; Hamajima N
Int J Infect Dis; 2019 Mar; 80():10-15. PubMed ID: 30572021
[TBL] [Abstract][Full Text] [Related]
65. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
Atalell KA; Birhan Tebeje N; Ekubagewargies DT
PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
[TBL] [Abstract][Full Text] [Related]
66. Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy.
Smith K; Kuhn L; Coovadia A; Meyers T; Hu CC; Reitz C; Barry G; Strehlau R; Sherman G; Abrams EJ
AIDS; 2009 Jun; 23(9):1097-107. PubMed ID: 19417581
[TBL] [Abstract][Full Text] [Related]
67. Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome.
Tran HT; Van den Bergh R; Loembé MM; Worodria W; Mayanja-Kizza H; Colebunders R; Mascart F; Stordeur P; Kestens L; De Baetselier P; Raes G;
AIDS; 2013 Jul; 27(11):1725-34. PubMed ID: 23807270
[TBL] [Abstract][Full Text] [Related]
68. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
69. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
Worodria W; Massinga-Loembe M; Mazakpwe D; Luzinda K; Menten J; Van Leth F; Mayanja-Kizza H; Kestens L; Mugerwa RD; Reiss P; Colebunders R;
J Acquir Immune Defic Syndr; 2011 Sep; 58(1):32-7. PubMed ID: 21654499
[TBL] [Abstract][Full Text] [Related]
70. Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China.
Xue M; Xie R; Pang Y; Yan S; Du Y; Guan C; Chen B
BMC Infect Dis; 2020 Jul; 20(1):554. PubMed ID: 32736608
[TBL] [Abstract][Full Text] [Related]
71. Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.
Melekhin VV; Shepherd BE; Stinnette SE; Rebeiro PF; Barkanic G; Raffanti SP; Sterling TR
PLoS One; 2009 Sep; 4(9):e6961. PubMed ID: 19742315
[TBL] [Abstract][Full Text] [Related]
72. Timing of antiretroviral therapy for HIV in the setting of TB treatment.
Piggott DA; Karakousis PC
Clin Dev Immunol; 2011; 2011():103917. PubMed ID: 21234380
[TBL] [Abstract][Full Text] [Related]
73. Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.
Writing Committee for the CASCADE Collaboration
Arch Intern Med; 2011 Sep; 171(17):1560-9. PubMed ID: 21949165
[TBL] [Abstract][Full Text] [Related]
74. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
Dheda K; Lampe FC; Johnson MA; Lipman MC
J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
[TBL] [Abstract][Full Text] [Related]
75. High rates of tuberculosis in patients accessing HAART in rural South Africa.
Naidoo K; Karim QA; Bhushan A; Naidoo K; Yende-Zuma N; McHunu PK; Frohlich J; Karim F; Upfold M; Kocheleff P; Abdool Karim SS
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):438-46. PubMed ID: 24256629
[TBL] [Abstract][Full Text] [Related]
76. Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania.
Bwana V; Tenu F; Magesa SM; Mfinanga SG
Tanzan J Health Res; 2011 Jan; 13(1):14-20. PubMed ID: 24409642
[TBL] [Abstract][Full Text] [Related]
77. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis.
Michailidis C; Pozniak AL; Mandalia S; Basnayake S; Nelson MR; Gazzard BG
Antivir Ther; 2005; 10(3):417-22. PubMed ID: 15918332
[TBL] [Abstract][Full Text] [Related]
78. Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.
Breton G; Bourgarit A; Pavy S; Bonnet D; Martinez V; Duval X; Longuet P; Abgrall S; Simon A; Leport C;
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1365-70. PubMed ID: 23107635
[TBL] [Abstract][Full Text] [Related]
79. Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
Bisson GP; Ramchandani R; Miyahara S; Mngqibisa R; Matoga M; Ngongondo M; Samaneka W; Koech L; Naidoo K; Rassool M; Kirui F; Banda P; Mave V; Kadam D; Leger P; Henestroza G; Manabe YC; Bao J; Kumwenda J; Gupta A; Hosseinipour MC;
AIDS; 2017 Oct; 31(16):2217-2225. PubMed ID: 28742529
[TBL] [Abstract][Full Text] [Related]
80. Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia: A Case-Control Study.
Deribe K; Yami A; Deribew A; Mesfin N; Colebunders R; Van Geertruyden JP; Woldie M; Maja T
J Int Assoc Provid AIDS Care; 2015; 14(3):269-73. PubMed ID: 23966102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
